43 reports

Angina (Angina Pectoris) (Cardiovascular) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Angina - Drugs In Development, 2021, provides an overview of the Angina (Cardiovascular) pipeline landscape. Angina pectoris is a term that describes...

  • Angina
  • World
  • Pharmaceutical Registrations
  • Surgical Procedures Performed

Angina (Angina Pectoris) - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Angina - Pipeline Review, H2 2020, provides an overview of the Angina (Cardiovascular) pipeline landscape. Angina pectoris is a term that describes chest pain caused...

  • Angina
  • World
  • Hospital Discharge

Angina Pectoris Drugs market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Angina Pectoris Drugs Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Angina Pectoris Drugs types, applications. Further, Angina...

  • Angina
  • World

Angina Pectoris Drugs Market Report Overview Angina Pectoris Drugs market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Angina Pectoris Drugs market types and applications. It is a focused study on Angina Pectoris Drugs market space including...

  • Angina
  • World
  • Health Provider Density

Angina (Angina Pectoris) - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Angina (Angina Pectoris) - Pipeline Review, H1 2020, provides an overview of the Angina (Angina Pectoris) (Cardiovascular) pipeline landscape. Angina pectoris is...

  • Angina
  • World
  • Surgical Procedures Performed

Abstract: - Global Angina Pectoris Drugs Market to Reach $14.3 Billion by 2027 - Amid the COVID-19 crisis, the global market for Angina Pectoris Drugs estimated at US$10 Billion in the year 2020, is projected to reach a revised size of US$14.3 Billion by 2027, growing at a CAGR of 5.3% over the analysis period 2020-2027....

  • Angina
  • Calcium Channel Blocker
  • World
  • China
  • United States

Refractory Angina (Cardiovascular) - Drugs in Development, 2021 Summary Refractory Angina (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Refractory Angina pipeline landscape. The report provides comprehensive information on the therapeutics under development for...

  • Angina
  • Cardiology
  • Therapy
  • Research And Development
  • World

Angina Pectoris: Epidemiology Forecast to 2028 Summary Angina pectoris is a chest pain or discomfort often described as squeezing, pressure, heaviness, or tightness in the chest and is caused by reduced blood flow to the heart (Mayo Clinic, 2020).The reduced blood flow occurs when arteries that...

  • Angina
  • United States
  • World
  • Smoking Prevalence
  • Mortality Rate

The global isosorbide market exhibited moderate growth during 2015-2020. Also known as D-Isosorbide dinitrate, isosorbide (C6H10O4) is a bio-product obtained from starch. The derivatives of isosorbide, namely isosorbide dinitrate and isosorbide mononitrate, find extensive applications across various end use industries...

  • Drug Delivery
  • Recycling
  • Bioproduct
  • Angina
  • Orthopedic Accessory
  • Epoxy Resin
  • Automotive
  • Fossil Fuel
  • World

2020 Angina (Angina Pectoris) PIPELINE HIGHLIGHTS Angina (Angina Pectoris) is one of the widely researched conditions during 2020 with 9 companies actively focusing on realizing pipeline’s potential. Development of Angina (Angina Pectoris) medicines is identified as integral to the strategy of the majority of companies...

  • Angina
  • World
  • Number Of Enterprises

High levels of pipeline activity are being observed in Angina (Angina Pectoris) treatment during 2019. Clinical development activities are being undertaken by more than 10 companies including Angionetics Inc, Beijing CoSci Med-Tech Co.,Ltd, Caladrius Biosciences Inc, G. Pohl-Boskamp GmbH & Co KG , Hemostemix Inc and others. A Significant...

  • Angina
  • World
  • Drug Approval

The ongoing clinical trial research report- “2019 Refractory Angina Ongoing Clinical Trials Study” analyzes the current scenario of all active Refractory Angina trials across the world. The report presents top level analysis of global Refractory Angina clinical trials across countries, companies and universities. It is designed to provide...

  • Clinical Trial
  • Angina
  • World
  • APAC

The ongoing clinical trial research report- “2019 Stable Angina Ongoing Clinical Trials Study” analyzes the current scenario of all active Stable Angina trials across the world. The report presents top level analysis of global Stable Angina clinical trials across countries, companies and universities. It is designed to provide clear understanding...

  • Angina
  • Clinical Trial
  • World
  • APAC

The ongoing clinical trial research report- “2019 Unstable Angina Ongoing Clinical Trials Study” analyzes the current scenario of all active Unstable Angina trials across the world. The report presents top level analysis of global Unstable Angina clinical trials across countries, companies and universities. It is designed to provide clear...

  • Angina
  • Clinical Trial
  • World
  • APAC

The ongoing clinical trial research report- “2019 Vasospastic Angina Ongoing Clinical Trials Study” analyzes the current scenario of all active Vasospastic Angina trials across the world. The report presents top level analysis of global Vasospastic Angina clinical trials across countries, companies and universities. It is designed to provide...

  • Clinical Trial
  • Angina
  • World
  • APAC

The ongoing clinical trial research report- “2019 Chronic Stable Angina Ongoing Clinical Trials Study” analyzes the current scenario of all active Chronic Stable Angina trials across the world. The report presents top level analysis of global Chronic Stable Angina clinical trials across countries, companies and universities. It is designed...

  • Angina
  • Clinical Trial
  • World
  • APAC

The global demand for Angina (Angina Pectoris) treatment options is emerging rapidly driven by consumption in major emerging markets. As more growth opportunities will turn up over the medium to long term future, a large number of companies are working on Angina (Angina Pectoris) pipeline. Companies quickly adapting to the change and moving...

  • Angina
  • World
  • Number Of Enterprises

The global clinical trial report- “2019 Stable Angina Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Stable Angina. It presents in-depth analysis of Stable Angina clinical trials across markets and companies. The research work is for providing complete understanding into trends in Stable Angina. The...

  • Angina
  • Clinical Trial
  • World

The global clinical trial report- “2019 Refractory Angina Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Refractory Angina. It presents in-depth analysis of Refractory Angina clinical trials across markets and companies. The research work is for providing complete understanding into trends in Refractory...

  • Clinical Trial
  • Angina
  • World

The global clinical trial report- “2019 Unstable Angina Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Unstable Angina. It presents in-depth analysis of Unstable Angina clinical trials across markets and companies. The research work is for providing complete understanding into trends in Unstable...

  • Angina
  • Clinical Trial
  • World

The global clinical trial report- “2019 Vasospastic Angina Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Vasospastic Angina. It presents in-depth analysis of Vasospastic Angina clinical trials across markets and companies. The research work is for providing complete understanding into trends in...

  • Clinical Trial
  • Angina
  • World

The Asia Pacific Spinal Cord Stimulation Devices Market would witness market growth of 9.3% CAGR during the forecast period (2019-2025). The growing geriatric population and favorable reimbursement and insurance approval measures are key variables influencing the rise of this industry. Strict governmental approvals and high device costs, however,...

  • Chronic Pain
  • Neuromodulation Device
  • Angina
  • Marketing Research
  • Clinical Trial
  • Neurological Disorder
  • Asia
  • APAC

Angina Pectoris: Global Drug Forecast and Market Analysis to 2028 Summary Angina pectoris, or angina for short, refers to chest pain or discomfort caused by insufficient blood supply to the heart muscle, known as myocardial ischemia, when myocardial oxygen demand exceeds oxygen supply.In chronic...

  • Angina
  • United States
  • Japan
  • World
  • Smoking Prevalence
  • Overweight Prevalence

Comprehensive Pipeline Review on Ongoing Clinical and Pre-clinical studies Angina (Angina Pectoris) Drug Development Pipeline Study is the latest publication from VPA Research with comprehensive information of Angina (Angina Pectoris) pipeline products. The Angina (Angina Pectoris) pipeline guide presents complete overview of...

  • Angina
  • World

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Angina Pectoris in 20 Major Markets Angina Pectoris (AP) is the term given to the pain or discomfort felt when the heart muscle lacks an adequate supply of oxygen rich blood (ischaemia). The main cause of angina is coronary arterial disease (CAD), which...

  • Angina
  • China
  • United States
  • South Korea
  • United Kingdom
  • India
  • Turkey
  • Italy
  • Mexico
  • Canada
  • Spain
  • France
  • Germany
  • Russia
  • Brazil
  • Poland
  • Japan
  • Argentina
  • Australia
  • Netherlands
  • Ireland
  • Chronic Disease Prevalence
  • Urban Population

Angina or Angina Pectoris market is estimated to be valued around $12 billion. It occurs when the blood flowing into coronary arteries fails to provide the required oxygen volumes. The main cause of this condition is Coronary heart disease. Unlike heart attack, Angina is temporary and does not cause any damage to the heart muscles. It is often...

  • Angina

Crossing a CTO with a guidewire demands surgical skill and patience. With the intention to make CTO crossings easier, faster and less reliant on a physician’s skill, a number of specialized devices have been developed to treat the condition. The procedure is risky, as arterial puncture can occur if the device is pushed out of the lumen, leading...

  • Cardiovascular Devices
  • Angina
  • Health Care Provider
  • United States

Angina (Angina Pectoris) ongoing clinical trials report provides comprehensive analysis and trends in global Angina (Angina Pectoris) disease clinical trials. The research work analyzes the ongoing Angina (Angina Pectoris) clinical trial trends across countries and companies. The report focuses on drugs and therapies being evaluated...

  • Angina
  • Clinical Trial
  • World

Refractory Angina ongoing clinical trials report provides comprehensive analysis and trends in global Refractory Angina disease clinical trials. The research work analyzes the ongoing Refractory Angina clinical trial trends across countries and companies. The report focuses on drugs and therapies being evaluated for Refractory Angina...

  • Clinical Trial
  • Angina
  • World

Stable Angina ongoing clinical trials report provides comprehensive analysis and trends in global Stable Angina disease clinical trials. The research work analyzes the ongoing Stable Angina clinical trial trends across countries and companies. The report focuses on drugs and therapies being evaluated for Stable Angina treatment in active...

  • Angina
  • Clinical Trial
  • World